EPO Patents = 2

Forward Citations = 53

Loading Chart...

13 inventors (with patents filed for the assignee):

Brent Richard Stranix (4 out of 20 patents)

Valérie Perron (2 out of 9 patents)

Guy Milot (2 out of 7 patents)

4. Jean-Marc Sabatier (1 out of 7 patents)

5. Jean-Emmanuel Bouchard (1 out of 3 patents)

6. Stephane Branchaud (1 out of 2 patents)

7. Pierre Du Ruisseau (1 out of 5 patents)

8. Kamel Mabrouk (1 out of 5 patents)

9. Herve Rochat (1 out of 4 patents)

10. Jonathan Reeves (1 out of 1 patent)

11. Edward Jerome Tanner (1 out of 1 patent)

12. Jurphaas Van Rietschoten (1 out of 3 patents)

13. Chandra J Panchal (1 out of 4 patents)

14. Abderrahim Bouzide (16 patents)

15. Gilles Sauve (2 patents)

6 patents: Sort by Forward Citations

1. 8283366 - Derivatives of pyridoxine for inhibiting HIV integrase (2012-10-09),

2. 8227450 - Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation (2012-07-24),

3. 8008297 - Lysine based compounds (2011-08-30),

4. 7534580 - PSP94 diagnostic reagents and assays (2009-05-19),

5. 7388008 - Lysine based compounds (2008-06-17),

6. 7285621 - Multiple branch peptide construction (2007-10-23),

Ambrilia Biopharma is a biotechnology company focused on the development of novel therapeutics in the areas of oncology, infectious diseases and dermatology. With a strong pipeline of innovative drugs and a commitment to advancing healthcare, Ambrilia is dedicated to improving the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

6 Patents

#157 in Montreal

#2,339 in Canada

Montreal, Canada

Ambrilia Biopharma, Inc.